amerson

Pharmaceuticals and Medical Products: Client Successes

In China marketplace where violation of intellectual property rights, high difficulties for innovation and technological advancement, highly fragmented and less efficient manufacturing capabilities, and relatively loose regulation are the norms of this industry, the speed of drug discovery to market can be significantly slowed by lack of understanding of these norms, Amerson Pharmaceuticals and Medical Products consultants strive to help companies become better informed, integrated, dynamically coordinated, and highly proactive by leveraging our deep rooted local know-how and powerful connection to top of China drug administration

By Subject

Technology Consulting (技术咨询）
    > FDA DMF(原料药主文档) 注册、FDA ANDA(普药申报注册）

Corporate Finance Management
    > A US growing pharmaceutical company: Going China through M&A

Offshore Outsourcing
    > A US growing biopharmaceutical company: Accelerated China Market Penetration through Packaged      Outsourcing Services Rendered by Amerson